The bwi product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
It was reported that a patient with history of lung resection underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered diaphragmatic paralysis.During the procedure while ablating the superior vena cava (svc), the physician carefully ablated where the diaphragm was captured.Physician immediately stopped the ablation when noticed the diaphragm was no longer captured by pacing.Phrenic nerve damage occurred.The patient did not show subjective symptoms.There¿s no indication that medical/surgical intervention or extended hospitalization was required.Patient¿s condition improved.The physician commented that it is possible that a previous lung resection operation was the cause of the issue.No bwi product malfunctions were experienced throughout the procedure.The contact force (cf) was between 2-12 grams with an average of 6 grams.The ablation was performed at 25 watts for 6 seconds.Since this event might result in permanent impairment of a body function or permanent damage of a body structure, then it is to be considered serious and mdr-reportable.
|
On 11/9/2020, the product investigation was completed.It was reported that a patient with history of lung resection underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered diaphragmatic paralysis.During the procedure while ablating the superior vena cava (svc), the physician carefully ablated where the diaphragm was captured.Physician immediately stopped the ablation when noticed the diaphragm was no longer captured by pacing.Phrenic nerve damage occurred.The patient did not show subjective symptoms.There¿s no indication that medical/surgical intervention or extended hospitalization was required.Patient¿s condition improved.The physician commented that it is possible that a previous lung resection operation was the cause of the issue.Device evaluation details: the device was visually inspected and it was found in good conditions.The magnetic, temperature and force features were tested and no issues were observed.In addition, the catheter was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed, and no internal actions related to the reported complaint were identified.The catheter passed all specifications.The root cause of the adverse event remains unknown.The instructions for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|